Assessment of Clinically Related Outcomes and Biomarker Analysis for Translational Integration in Colorectal Cancer

ConditionColorectal Cancer

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorHelse Stavanger HF

About this trial

* A prospective, observational study on clinical outcomes of surgical management of primary and metastatic colorectal cancer * Prospective collection of tissues to explore potential biomarkers in blood and/or primary or secondary cancers and/or normal colon

Eligibility criteria

Qualifiers

Diagnosis of colorectal cancer, primary or metastatic (liver), with a treatment intention of planned curative surgery

Informed consent to participate

Age ≥18

Disqualifiers

failure to provide written informed consent

Trial design

Treatments tested in this trial

open and laparoscopic surgery

Treatment groups

1,200 Participants

are divided into 1 treatment group

Sponsors and collaborators

Helse Stavanger HF

Lead sponsor

Source ClinicalTrials.gov